Minyong Li Selected Research

Tubulin Modulators

5/2022

Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minyong Li Research Topics

Disease

29	Neoplasms (Cancer) 08/2022 - 03/2010
6	Pathologic Processes 01/2022 - 06/2008
4	Inflammation (Inflammations) 01/2022 - 10/2009
4	Neoplasm Metastasis (Metastasis) 11/2017 - 08/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2011
3	Human Influenza (Influenza) 04/2011 - 09/2006
2	Squamous Cell Carcinoma of Head and Neck 08/2022 - 05/2022
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 04/2017
2	Obesity 01/2022 - 12/2021
2	Hypoxia (Hypoxemia) 01/2019 - 11/2017
2	Metabolic Diseases (Metabolic Disease) 01/2018 - 04/2017
2	Cardiotoxicity 12/2015 - 01/2009
2	Cardiac Arrhythmias (Arrythmia) 04/2014 - 04/2007
1	Pheochromocytoma 01/2022
1	Phototoxic Dermatitis (Phototoxicity) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Necrosis 01/2022
1	Mouth Neoplasms (Oral Cancer) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2021
1	Sulfite oxidase deficiency 08/2020
1	Stormorken Syndrome 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2019
1	Male Infertility (Male Sterility) 12/2019
1	Idiopathic Pulmonary Fibrosis 12/2019
1	Fibrosis (Cirrhosis) 12/2019
1	Sepsis (Septicemia) 10/2019
1	Albinism 12/2018
1	Melanoma (Melanoma, Malignant) 12/2018
1	Melanosis (Freckles) 12/2018
1	Hyperpigmentation 12/2018
1	Starvation 01/2018
1	Lung Neoplasms (Lung Cancer) 08/2017
1	Colorectal Neoplasms (Colorectal Cancer) 03/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Long QT Syndrome 12/2015
1	Asthma (Bronchial Asthma) 09/2010
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2010

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
7	EnzymesIBA 01/2020 - 03/2010
5	Biological ProductsIBA 08/2022 - 04/2011
5	Pharmaceutical PreparationsIBA 05/2022 - 04/2014
3	Therapeutic UsesIBA 08/2022 - 01/2009
3	Fluorescent Dyes (Fluorescent Probes)IBA 01/2020 - 03/2016
3	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2011 - 08/2010
2	parbendazoleIBA 08/2022 - 05/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2010
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 06/2008
2	Calcium Release Activated Calcium ChannelsIBA 01/2020 - 01/2016
2	NitroreductasesIBA 12/2017 - 01/2016
2	Oxidoreductases (Dehydrogenase)IBA 01/2016 - 01/2009
2	Potassium Channels (Potassium Channel)IBA 12/2015 - 04/2007
2	Histone Deacetylases (Histone Deacetylase)IBA 04/2015 - 03/2010
2	Neuraminidase (Sialidase)IBA 04/2011 - 01/2009
2	ubenimexIBA 01/2011 - 01/2011
2	Hemagglutinins (Hemagglutinin)IBA 01/2009 - 09/2006
1	AnthelminticsIBA 05/2022
1	Tubulin ModulatorsIBA 05/2022
1	Phosphotransferases (Kinase)IBA 02/2022
1	chloro(triethylphosphine)gold(I)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	Thioredoxin-Disulfide ReductaseIBA 01/2022
1	Food Additives (Food Additive)IBA 12/2021
1	Sweetening Agents (Sweeteners)IBA 12/2021
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 11/2021
1	Proteolysis Targeting ChimeraIBA 10/2021
1	Pyroglutamyl-Peptidase IIBA 01/2021
1	Sulfates (Sulfates, Inorganic)IBA 08/2020
1	SulfitesIBA 08/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	SeleniumIBA 12/2019
1	SelenocysteineIBA 12/2019
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 12/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2019
1	compound FP 1IBA 10/2019
1	IronIBA 10/2019
1	MetalsIBA 10/2019
1	CalcineurinIBA 01/2019
1	CopperIBA 12/2018
1	Monophenol Monooxygenase (Tyrosinase)IBA 12/2018
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2018
1	pantetheinase (pantetheine hydrolase)IBA 01/2018
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2018
1	MercuryIBA 01/2018
1	coelenterazineIBA 12/2017
1	NADP (NADPH)IBA 11/2017
1	Nonesterified Fatty Acids (NEFA)IBA 04/2017
1	AstemizoleIBA 03/2016
1	Ether (Diethyl Ether)IBA 12/2015
1	Histone Deacetylase InhibitorsIBA 11/2013
1	Threonine (L-Threonine)FDA Link 09/2011
1	PhosphoserineIBA 09/2011
1	Oseltamivir (Tamiflu)FDA Link 04/2011
1	ThiazolidinesIBA 04/2011
1	thiazolidine-4-carboxylic acidIBA 04/2011

Therapy/Procedure

7	Therapeutics 08/2022 - 02/2013
2	Drug Therapy (Chemotherapy) 08/2022 - 05/2022
2	Phototherapy (Light Therapy) 01/2022 - 01/2018